Partner Social Media Toolkit

〰️

Partner Social Media Toolkit 〰️

Overview

The Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs) at the Commonwealth Heads of Government Meeting (CHOGM) will be an important milestone for NTD community – an opportunity to showcase the partnerships and commitments that have driven progress over the past decade, and a platform to galvanize support for the 2030 goals.

Medicines donated by pharmaceutical companies through WHO are a pillar in the fight against NTDs. These donation programs, many which have existed for decades, cover a significant proportion of the cost of interventions. More than 14 billion doses have been donated by these companies since the London Declaration was signed in 2012.

The CEO Roundtable is working closely with companies, Uniting to Combat NTDs and other partners to tell the crucial role that  industry has played in the lead up to the Kigali Summit. This effort will help to give partners resources to tell the full NTD story. A story built on collaboration and hard earned gains—focused on industry’s ongoing commitment to NTDs. This toolkit serves as a companion to Uniting’s Kigali Summit Social Toolkit, and emphasizes the role companies have played in the NTD community.

 

Key Messages

  • The London Declaration on NTDs has been a major public health success. As a result of this historic effort, 45 countries have eliminated at least one NTD; hundreds of millions more people receive necessary treatments every year; and more than 600 million people no longer require preventive treatment.

  • Progress against NTDs reduces the enormous burden these diseases place on some of the poorest communities in the world - these programs are an investment in reducing global poverty and creating a fairer, healthier world for all. 

  • Partnerships between the private, public and non-profit sectors have been invaluable to this success. Close coordination and planning has helped ensure that medicines donated by pharmaceutical companies reach people in need, and that new therapies and diagnostics are developed and delivered.

  • In the last decade, the private sector has donated more than 14 billion NTD treatments; developed several new therapies and diagnostics, and worked closely with country governments and NGOs to solve supply chain problems to ensure that all donated medicines are delivered to people in need.

  • The COVID-19 pandemic caused widespread disruptions to essential health services, including NTD treatment. It is critical to restore these services and make up for lost ground. The WHO’s 2030 Roadmap gives us the right path forward, if we can all work together.

  • The world has never been closer to beating these diseases. If we continue the partnership of the last decade and make investments, we can see the end of many diseases. We have the tools to reduce the impact of NTDs, and now we have to mobilize them to reach the last mile.

  • On June 23, global partners including the pharmaceutical industry will gather in Kigali, Rwanda to renew their commitments to this partnership. You can read more about the Kigali Declaration here.

 

Hashtags

The official theme of the Kigali Summit is Unlock the Potential. 

Primary summit hashtags: 

  • #UnlockThePotential 

  • #KigaliSummit

NTD-specific hashtags:

  • #BeatNTDs

  • #PlayYourPart

  • #100PercentCommitted


Graphics and Other Assets

You can view and download the graphics in this toolkit here.

Additional Assets

Graphics from Uniting’s Kigali Summit Social Media Toolkit. The toolkit can be found here and graphics can be found here.


Sample Social Content

〰️

Sample Social Content 〰️

Theme 1: Historic Impact

The world has made impressive progress in the fight against NTDs. Over the past decade, there have been significant advances in advocacy, control, implementation, funding, cross-sectoral collaboration, and drug donation for NTDs.

  • Sample Tweet 1

    “For years, NTDs threatened the health of ½ the world’s population - yet we rarely hear about them. Thanks to a dedicated group of partners, supported by donations from pharma companies, we’re ending the neglect. #UnlockThePotential“

    Suggested graphic: Timeline

  • Sample Tweet 2

    “How often can we say we’ve ELIMINATED a disease? Well, 45 countries have eliminated at least one NTD, and that # is growing. This public health achievement is due in part to the industry partners who have donated drugs, invested in R&D, and strengthened supply chains. #BeatNTDs”

    Suggested graphic: Map

  • Sample Tweet 3

    “The Guinness Record for “Most medication donated in 24 hours” - 207,169,292 doses - is held by 10 pharma companies for a historic donation of #NTD meds in 2017.

    Even more incredible? This is only a fraction of what they’ve donated in the past 10 years.

    https://unitingtocombatntds.org/news/guinness-world-record-2017/

  • Sample Post 1

    The Guinness World Record for “Most medication donated in 24 hours” is 207,169,292 doses. This incredible record is held by 10 pharma companies for a historic donation of treatments for a neglected tropical disease (NTDs) in 2017.

    Even more incredible? This is only a fraction of what they’ve donated in the past 10 years. Together, these companies have donated over 14 billion treatments to end the public health threat of NTDs.

    Read more about this incredible effort here: https://unitingtocombatntds.org/news/guinness-world-record-2017/

  • Sample Post 2

    Each year neglected tropical diseases (NTDs) impacts 1.7 billion people worldwide, accounting for 1% of the global disease burden - yet we rarely hear about their impact. These diseases sicken and kill millions annually, keep adults out of work and children out of school, and help entrench a cycle of poverty. These diseases are preventable and treatable - the fact that so many people suffer is a global health injustice.

    Behind the scenes, large-scale campaigns are helping billions access treatment. Together, a group of 10 pharmaceutical companies have donated over 14 billion doses of treatment to endemic countries. Thanks to this partnership, 600 million fewer people require interventions against several NTDs than in 2010, and 45 countries have eliminated at least one disease.

    The world is closer than ever to ending NTDs as a public health threat, but we can’t afford to stop now. That’s why on June 23, partners in the fight against NTDs - including the pharmaceutical companies - will gather in Kigali to renew their commitments to the fight. Learn more about about the Summit here: https://unitingtocombatntds.org/news/rwanda-to-host-first-ever-global-summit-on-malaria-and-neglected-tropical-diseases/

Theme 2: R&D and Innovation

In addition to drug donations, companies also focus on R&D for diagnostics and treatments, helping to fill in critical gaps and accelerate efforts to control, eliminate, and eradicate neglected tropical diseases by trialing new medicines and diagnostics technologies, resolving supply chain issues, and investing in global manufacturing capacity. Innovation is one of the key themes at the Kigali Summit.

  • Sample Tweet 1

    “To accelerate progress against #NTDs, @DNDi and pharma companies are working together to discover and scale up access to effective treatments. Learn more about the work they’re doing to #UnlockThePotential of science to beat NTDs.”

  • Sample Tweet 2

    #NTDs are some of humanity's oldest diseases, but new innovations in medicines and diagnostics are helping accelerate progress towards ending these devastating diseases. Learn more about the work of companies and partners to help achieve @WHO’s NTD targets: https://unitingtocombatntds.org/kigali-declaration/

    Suggested graphic: Timeline

  • Sample Tweet 3

    Drug donations by industry partners are a pillar of #NTD programs, but their work doesn’t end there. To #UnlockThePotential of innovation, companies continue to:

    👉Trial new medications

    👉Invest in manufacturing & lab capacity globally

    👉Explore new tech, like AI, for diagnostics

  • Sample Post 1

    Drug donations by industry partners have been a pillar of the fight against #NTDs for decades. But that doesn’t mean they’re relying on dated tools. Together, companies have continued innovating in order to help accelerate progress against these devastating diseases.

    This includes:
    👉Running clinical trials for new medications and vaccines for diseases;
    👉 Investing in drug manufacturing and laboratory capacity globally; and
    👉 Exploring the use for new technologies, including AI, for diagnostics.

    These tools will help #UnlockThePotential of country programs to control, eliminate, and eradicate NTDs.

  • Sample Post 2

    Neglected tropical diseases (NTDs) are a group of 20 debilitating diseases that impact over 1.7 billion people, predominantly in impoverished communities. While many of these diseases are preventable and treatable, some current treatments are only partially effective, come with severe side effects, or are not formulated for children.

    To accelerate progress against NTDs, pharmaceutical companies continue to research, develop, and scale up access to effective new treatments. Learn more about the work they’re doing to #UnlockThePotential of science to beat NTDs.

Theme 3: Public-Private Partnerships

Partnership between the private, public and non-profit sectors has been invaluable to progress on NTDs. Maintaining and strengthening these partnerships will be critical to achieving the ambitious targets of WHO’s 2030 Roadmap

  • Sample Tweet 1

    #NTDs have afflicted humans for centuries. Since 2012, pharma companies have delivered >14 billion drugs to endemic countries, helping to eliminate at least one NTD in 39 countries.

    Great things happen when we #UnlockThePotential of public-private partnerships to improve health.

    Suggested graphic: Timeline

  • Sample Tweet 2

    For decades, pharma companies have supported the fight to #BeatNTDs by:

    💊Donating drugs
    💸Investing in R&D
    🏥Strengthening health systems
    🤝Supporting country leadership

    On June 23, pharma is joining partners in Kigali to renew their commitment:
    https://unitingtocombatntds.org/news/rwanda-to-host-first-ever-global-summit-on-malaria-and-neglected-tropical-diseases/

    Suggested graphic: Commitments

  • Sample Tweet 3

    In today’s world where good news is hard to come by, one story of collaboration stands out: the historic public-private partnership to combat #NTDs. Anchored by donations from pharma companies, this group has helped free millions from the threat of NTDs.

    https://www.economist.com/international/2017/04/22/a-global-attack-on-long-neglected-tropical-diseases-is-succeeding

  • Sample Tweet 4

    Each year #NTDs affect 1.7b people - yet we rarely hear about their impact. Behind the scenes, a historic partnership, anchored by donations from pharma companies, helps billions access treatment. Amazing things happen when we #UnlockThePotential of public-private partnerships.

    Suggested graphic: Drug donations

  • Sample Post 1

    Drug donations by industry partners have been a pillar of the fight against #NTDs for decades. But that doesn’t mean they’re relying on dated tools. Together, companies have continued innovating in order to help accelerate progress against these devastating diseases.

    This includes:
    👉Running clinical trials for new medications and vaccines for diseases;
    👉 Investing in drug manufacturing and laboratory capacity globally; and
    👉 Exploring the use for new technologies, including AI, for diagnostics.

    These tools will help #UnlockThePotential of country programs to control, eliminate, and eradicate NTDs.

  • Sample Post 2

    Neglected tropical diseases (NTDs) are a group of 20 debilitating diseases that impact over 1.7 billion people, predominantly in impoverished communities. While many of these diseases are preventable and treatable, some current treatments are only partially effective, come with severe side effects, or are not formulated for children.

    To accelerate progress against NTDs, pharmaceutical companies continue to research, develop, and scale up access to effective new treatments. Learn more about the work they’re doing to #UnlockThePotential of science to beat NTDs.

Social Media Handles

We encourage you to engage with content from key partners’ social media platforms.

Pharmaceutical Companies

Bayer
Twitter: @Bayer, @BayerUS 

Eisai
Twitter: @EisaiUS, @EisaiPharma, @EisaiSDGs

Gilead
Twitter: @GileadSciences

GSK
Twitter: @GSK, @GSKUS

J&J
Twitter: @JNJNews

Merck
Twitter: @Merck 

Merck KGaA

Novartis
Twitter: @Novartis

Pfizer
Twitter: @pfizer 

Sanofi
Twitter: @Sanofi, @SanofiUS

Partners

Rwandan Government
Twitter: @RwandaGov

Uniting to Combat NTDs
Twitter: @CombatNTDs

CHOGM
Twitter: @CHOGM2022

Gates Foundation
Twitter: @gatesfoundation
LinkedIn: Bill & Melinda Gates Foundation

END Fund
Twitter: @TheENDFund

DNDi
Twitter: @DNDi

Sight Savers
Twitter: @Sightsavers